CRBX.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Specialty Business Services

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$58M	+71.5%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CRBX.STCarbiotix AB	$6.58	+14.24%	$33M	—
CIRCHE.STCirChem AB (publ)	$0.59	-0.34%	$20M	—
HEGR.STHedera Group AB (publ)	$0.43	+8.50%	$15M	—
HELIO.STHeliospectra AB (publ)	$0.09	+0.00%	$56M	—
HEXI.STHexicon AB (publ)	$0.11	-3.08%	$40M	—
IRIS.STIrisity AB (publ)	$0.27	-6.32%	$103M	—
MANTEX.STMantex AB (publ)	$6.74	+0.90%	$15M	—

Source: Financial Modeling Prep · peers by sector/industry

Carbiotix AB

Carbiotix AB is a therapeutics company currently in the pre-clinical development stage. It specializes in creating products and medicines intended to stimulate beneficial bacteria in the gut, with the aim of addressing metabolic and chronic illnesses. The company was established in 2014 and is headquartered in Lund, Sweden.

www.carbiotix.com

Employees: 8
IPO / List date: Oct 21, 2019
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds CRBX.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CRBX.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CRBX.ST yet.